Meditation to Reduce Stress and Improve Quality of Life

Sponsor
Mayo Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT01047917
Collaborator
(none)
17
1
1
1
16.7

Study Details

Study Description

Brief Summary

The purpose of this study is to test a simple meditation program that is easy to learn; inexpensive; easy to practice; non-religion based; and has wide applicability to multiple medical conditions. This program has been developed by the Complementary and Integrative Medicine Program at the Mayo Clinic.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Meditation DVD
N/A

Detailed Description

Stress is a ubiquitous problem and a mediator of symptoms for a variety of medical conditions. Most medical diagnoses, procedures, and physician visits are associated with considerable stress. Excessive stress is associated with adverse medical outcomes, unhealthy coping mechanisms, symptoms of anxiety and depression, and overall a poor quality of life. No specific pharmacologic treatment is available for treating stress. Further, it is often difficult or impossible to change the reality of circumstances causing stress in an individual. Thus increasing individual coping mechanisms and ability of a person to handle stress, rather than changing the stressors itself, might be a more feasible approach towards reducing stress.

Meditation is a widely used and increasingly popular intervention that positively affects the individual at cognitive, physical, emotional, behavioral, and spiritual levels. A practice of meditation has been shown to reduce symptoms of stress and improve overall quality of life. Several meditation programs exist, however most are limited by considerable expense, need for elaborate training, lack of widespread availability, or incorporation of ideas and practices unique to a particular culture.

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Meditation to Reduce Stress and Improve Quality of Life: A Feasibility Study
Study Start Date :
Mar 1, 2008
Actual Primary Completion Date :
Apr 1, 2008
Actual Study Completion Date :
Apr 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Meditation DVD

All participants will receive a Meditation DVD to practice at home daily for a total of 4 weeks.

Behavioral: Meditation DVD
Participants will undergo a one-hour group instruction session in meditation held by Dr. Amit Sood. Participants will then receive a DVD to practice the intervention at home daily for a total of 4 weeks. The DVD will have 3 different programs of 5, 15, and 30 minutes each loaded on it with a menu option to choose one of the programs.
Other Names:
  • Meditation
  • Outcome Measures

    Primary Outcome Measures

    1. To assess the feasibility of incorporating a 4-week innovative meditation program into the daily activities of healthy Mayo Clinic employees for improving stress. [4 Weeks]

    Secondary Outcome Measures

    1. To assess the effect of a 4-week program of meditation on perceived stress and overall quality of life compared to baseline. [4 Weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • At least 18 years of age

    • Good general health

    • Access to a DVD player

    • Provided with, understand, and have signed the informed consent

    Exclusion Criteria:
    • Are currently using (at the time of enrollment) antipsychotics or recently (< 3 months) started on antidepressants. Patients on stable dose of antidepressant (for ≥ 3 months) will be allowed.

    • Have a lifetime history of schizophrenia

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: Dietlind L. Wahner-Roedler, M.D., Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dietlind Wahner-Roedler, Principal Investigator, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT01047917
    Other Study ID Numbers:
    • 07-006601
    First Posted:
    Jan 13, 2010
    Last Update Posted:
    Jan 6, 2012
    Last Verified:
    Jan 1, 2012
    Keywords provided by Dietlind Wahner-Roedler, Principal Investigator, Mayo Clinic

    Study Results

    No Results Posted as of Jan 6, 2012